CAPITAL PHARMACY — Lansoprazole Importer Profile
Pharmaceutical Importer · #7 buyer for Lansoprazole · $1.2M import value · 24 shipments · OMAN · DGFT Verified
CAPITAL PHARMACY is the #7 importer of Lansoprazole from India with $1.2M in import value and 24 verified shipments. CAPITAL PHARMACY holds a 0.4% market share in Lansoprazole imports based in OMAN. The company sources from 1 verified supplier across 15 formulations shipped to 1 country. Overall, CAPITAL PHARMACY imports 2 pharmaceutical products worth $2.3M across 2 therapeutic categories.
CAPITAL PHARMACY — Lansoprazole Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Lansoprazole to CAPITAL PHARMACY?
Verified from 24 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| CIPLA LIMITED | $1.2M | 24 | 100.0% |
CAPITAL PHARMACY sources Lansoprazole from 1 verified Indian supplier based on 24 customs records. The primary supplier is CIPLA LIMITED accounting for 100.0% of imports.
How Does CAPITAL PHARMACY Compare to Nearest Lansoprazole Importers?
Buyers ranked immediately above and below #7 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 3 | MYLAN PHARMACEUTICALS INC, | UNITED STATES | $1.7M | 34 | $50.0K |
| 8 | CSP VIATRIS SANTE AT CSP- LAB, | FRANCE | $1.4M | 28 | $50.0K |
| 7 | CAPITAL PHARMACY ★ | OMAN | $1.2M | 24 | $50.0K |
| 11 | ASCEND LABORATORIES,LLC | UNITED STATES | $1.1M | 22 | $50.0K |
| 12 | MYLAN PHARMACEUTICALS INC | UNITED STATES | $1.1M | 22 | $50.0K |
CAPITAL PHARMACY ranks #7 among 687 Lansoprazole importers from India. Average shipment value of $50.0K compared to the market average of $28.3K. The closest competitors by value are MYLAN PHARMACEUTICALS INC, and CSP VIATRIS SANTE AT CSP- LAB,.
Where Does CAPITAL PHARMACY Import Lansoprazole To?
Destination countries from 24 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| OMAN | $1.2M | 24 | 100.0% |
CAPITAL PHARMACY imports Lansoprazole to 1 country. The primary destination is OMAN receiving 100.0% of shipments worth $1.2M.
What Lansoprazole Formulations Does CAPITAL PHARMACY Import?
| Formulation | Value | Shipments |
|---|---|---|
| LANZOL 30 CAPSULES (LANSOPRAZOLE 30MG) ( | $300.0K | 6 |
| LANZOL 30 CAPSULES LANSOPRAZOLE 30MG | $150.0K | 3 |
| LANZOL 30 CAPSULES LANSOPRAZOLE 30MG INV QTY 25200 PACK 3X10S 756000 NOS | $100.0K | 2 |
| LANZOL 30 CAPSULES (LANSOPRAZOLE 30MG) (26352 PACKx3x10'S=790560 NOS) | $100.0K | 2 |
| LANZOL 30 CAPSULES LANSOPRAZOLE 30MG INV QTY 25255 PACK 3X10S 757650 NOS | $50.0K | 1 |
| LANZOL 30 CAPSULES (LANSOPRAZOLE 30MG) (INV.QTY.25744 PACK 3X10S=772320 NOS) | $50.0K | 1 |
| LANZOL 30 CAPSULES (LANSOPRAZOLE 30MG) (INV.QTY.25376 PACK 3X10S=761280 NOS) | $50.0K | 1 |
| LANZOL 30 CAPSULES (LANSOPRAZOLE 30MG) (INV.QTY.25344 PACK 3X10S=760320 NOS) | $50.0K | 1 |
| LANZOL 30 CAPSULES (LANSOPRAZOLE 30MG) (INV.QTY.25288 PACK 3X10S=758640 NOS) | $50.0K | 1 |
| LANZOL 30 CAPSULES (LANSOPRAZOLE 30MG). (INV.QTY. 26272 PACK 3 X10 'S= 788160 NOS) | $50.0K | 1 |
CAPITAL PHARMACY imports 15 distinct Lansoprazole formulations from India. The top formulation is LANZOL 30 CAPSULES (LANSOPRAZOLE 30MG) ( with 6 shipments worth $300.0K.
Who Are the Top Buyers of Lansoprazole from India and How Much Does CAPITAL PHARMACY Import?
India exported $19.5M worth of Lansoprazole through 4,867 shipments from 316 suppliers to 105 countries, serving 687 buyers globally. CAPITAL PHARMACY imports $1.2M of this total, accounting for 0.4% of India's Lansoprazole exports with 24 shipments from OMAN. This is verified from 24 customs shipment records covering 15 distinct formulations.
What Is the Average Order Value for CAPITAL PHARMACY's Lansoprazole Imports?
CAPITAL PHARMACY's average Lansoprazole order value is $49.9K per consignment, based on 24 shipments totaling $1.2M. CAPITAL PHARMACY is based in OMAN and ranks #7 among all Lansoprazole importers from India by value. The company sources from 1 verified supplier in India.
Who Supplies Lansoprazole to CAPITAL PHARMACY?
CAPITAL PHARMACY sources Lansoprazole from 1 verified Indian supplier: CIPLA LIMITED ($1.2M, 100.0%). This is based on 24 customs records.
How Does CAPITAL PHARMACY Compare to Other Lansoprazole Importers?
CAPITAL PHARMACY ranks #7 among 687 Lansoprazole importers from India with a 0.4% market share. The top 3 importers are MYLAN IRELAND C/O ALLOGA RDC, ($3.2M), NUEVOS ETICOS NEOETHICALS, S.A. ($2.8M), EVERSANA LIFE SCIENCE SERVICES ($1.9M). CAPITAL PHARMACY processed 24 shipments from OMAN.
About CAPITAL PHARMACY
CAPITAL PHARMACY imports 2 products worth $2.3M. Beyond Lansoprazole, top products include Budesonide. View the complete CAPITAL PHARMACY profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Lansoprazole — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Lansoprazole shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: CAPITAL PHARMACY matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as CAPITAL PHARMACY's capped import value divided by total capped export value for Lansoprazole across all Indian exporters.
- 5.Verified Records: This page is backed by 24 individual customs records matching CAPITAL PHARMACY importing Lansoprazole, covering 15 formulations from 1 verified supplier.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 105+ countries, 687+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Lansoprazole Import Data for CAPITAL PHARMACY
Access order-level details, pricing data, supplier connections, and competitive analysis for CAPITAL PHARMACY's Lansoprazole imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
CAPITAL PHARMACY
Full Company Profile →
2 products · $2.3M total trade · 2 categories
CAPITAL PHARMACY × Lansoprazole
Verified from customs records
Company Overview
Top Products by CAPITAL PHARMACY
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for CAPITAL PHARMACY.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Lansoprazole. For current order-level data, contact TransData Nexus.